connected insulin pen
Bigfoot has agreed to develop and commercialize new programs that will integrate with Abbott's diabetes management platform.
Abbott joins Dexcom, Glooko and Roche as a data-sharing partner for the as-yet-unlaunched device.
Keeping track of insulin dosage and figuring out the right injection angle can be a challenge for people living with diabetes.